Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Kris Elverum has more than 12 years of experience in the pharmaceutical/biotech industry, with expertise in corporate strategy, business development, commercial and operations. He joined Turnstone Biologics from SQZ Biotech, a pre-clinical stage biotechnology company developing cell therapies, where he was Chief Business Officer. Prior to that, he led the U.S. commercial model for CTL019, Novartis’ breakthrough CAR-T cell therapy, and other CAR-T cell immunotherapies. Earlier in his career, he held various commercial roles for Novartis Pharmaceuticals and served as Global Head of Strategy for Sandoz. Before that, he was an Engagement Manager with McKinsey & Co. where he served clients across the healthcare value chain. Kris earned an M.B.A. and a B.S. from the University of Minnesota’s Carlson School of Management.